Syntara Limited (SNT) is a clinical stage drug development company targeting extracellular matrix dysfunction with its expertise in amine oxidase chemistry and other technologies to develop medicines for blood cancers and conditions linked to inflammation and fibrosis.
Find out what a historical investment in Syntara would be worth today using our SNT stock calculator.
Buying SNT shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Syntara in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in SNT
What is the ticker symbol of Syntara?
The ticker symbol for Syntara is SNT.
How much is one share of SNT?
One share of SNT is valued at $0.01 as of 20 November 2026.
What is the market capitalisation of Syntara SNT?
As of 20 November 2026 Syntara has a market cap of $27.5M.
What is the P/E ratio of SNT?
The Price to Earnings ratio of SNT is -2.78.
What is the Earnings Per Share of SNT?
The Earnings Per Share of SNT is -$0.01.
What is the 52-week high for Syntara stock?
The Syntara 52-week high stock price is $0.04.
What is the 52-week low for Syntara stock?
The Syntara 52-week low stock price is $0.01.
Can I buy SNT shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy SNT shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.